JPRN-UMIN000035854已完成未知
Tofacitinib therapy for rheumatoid arthritis : a direct comparison study between biologic-naive and experienced patients. - Efficacy of tofacitinib for rheumatoid arthritis patients in Japan.
ational Hospital Organization0 个研究点目标入组 100 人开始时间: 2019年2月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
Although tofacitinib can provide an effective treatment option for intractable RA patients. its impact on outcomes in lowere in patinets with previous failure.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have previously recieved tofacitinib therapy.
研究者
相似试验
已完成
4 期
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RAArthritis, RheumatoidNCT04928066Qilu Hospital of Shandong University100
招募中
2 期
Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.Rheumatoid ArthritisInterstitial Lung DiseaseNCT05246293National Institute of Respiratory Diseases, Mexico60
已完成
不适用
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World SettingArthritis, RheumatoidNCT05487703Pfizer318
已完成
4 期
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA PatientsRheumatic ArthritisNCT04485325Dr. Frank Behrens92
Unknown
不适用
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated SpondyloarthropathySpondyloarthropathyUlcerative ColitisNCT05431283Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)100